Consensus Recommendations – Bladder Cancer

EAU–ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

Published in 2019 – Ann Oncol 00: 1–30, 2019
Authors: A. Horwich, M. Babjuk, J. Bellmunt, H. M. Bruins, T. M. D. Reijke, M. D. Santis, S. Gillessen, N. James, S. Maclennan, J. Palou, T. Powles, M. J. Ribal, S. F. Shariat, T. V. D. Kwast, E. Xylinas, N. Agarwal, T. Arends, A. Bamias, A. Birtle, P. C. Black, B. H. Bochner, M. Bolla, J. L. Boormans, A. Bossi, A. Brigant, I. Brummelhuis, M. Burger, D. Castellano, R. Cathomas, A. Chiti, A. Choudhury, E. Compérat, S. Crabb, S. Culine, B. D. Bari, W. D. Blok, P. D. Visschere, K. Decaestecker, K. Dimitropoulos, J. L. D. Escrig, S. Fanti, V. Fonteyne, M. Frydenberg, J. J. Futterer, G. Gakis, B. Geavlete, P. Gontero, B. Grubmüller, S. Hafeez, D. E. Hansel, A. Hartmann, D. Hayne, A. M. Henry, V. Hernandez, H. Herr, K. Herrmann, P. Hoskin, J. Huguet, B. A. Jereczek-Fossa, R. Jones, A. M. Kamat, V. Khoo, A. E. Kiltie, S. Krege, S. Ladoire, P. C. Lara, A. Leliveld, E. Linares-Espinós, V. Løgager, A. Lorch, Y. Loriot, R. Meijer, M. C. Mir, M. Moschini, H. Mostafid, A.-C. Müller, C. R. Müller, J. N’Dow, A. Necchi, Y. Neuzillet, J. R. Oddens, J. Oldenburg, S. Osanto, W. Oyen, L. Pacheco-Figueiredo, H. Pappot, M. I. Patel, B. R. Pieters, K. Plass, M. Remzi, M. Retz, J. Richenberg, M. Rink, F. Roghmann, J. Rosenberg, M. Roupret, O. Rouviere, C. Salembier, A. Salminen, P. Sargos, S. Sengupta, A. Sherif, R. J. Smeenk, A. Smits, A. Stenzl, G. N. Thalmann, B. Tombal, B. Turkbey, S. V. Lauridsen, R. Valdagni, A. G. V. D. Heijden, H. V. Poppel, M. D. Vartolomei, E. Veskimäe, A. Vilaseca, F. A. V. Rivera, T. Wiegel, P. Wiklund, A. Williams, R. Zigeuner & J. A. Witjes

The EAU–ESMO consensus conference manuscript reports findings from a multidisciplinary group of professional societies and world-leading experts in the management of advanced and variant bladder cancer. The group developed consensus statements using a Delphi survey and consensus conference approach in order to provide guidance on controversial issues surrounding the diagnosis, treatment and follow-up.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings